IDEXX Laboratories's EPS (Basic) for the
three
months ended in Jun. 2024 was $2.46.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was $10.19.
During the past 12 months, IDEXX Laboratories's average EPS without NRIGrowth Rate was 13.00% per year.
During the past 3 years, the average EPS without NRIGrowth Rate was 14.80% per year.
During the past 5 years, the average EPS without NRIGrowth Rate was 19.00% per year.
During the past 10 years, the average EPS without NRIGrowth Rate was 21.70% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.
During the past 13 years, IDEXX Laboratories's highest 3-Year average EPS without NRI Growth Rate was 139.00% per year. The lowest was -47.10% per year. And the median was 17.60% per year.
IDEXX Laboratories EPS (Diluted) Historical Data
The historical data trend for IDEXX Laboratories's EPS (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of IDEXX Laboratories's EPS (Diluted)
For the Diagnostics & Research subindustry, IDEXX Laboratories's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
IDEXX Laboratories's PE Ratio Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, IDEXX Laboratories's PE Ratio distribution charts can be found below:
* The bar in red indicates where IDEXX Laboratories's PE Ratio falls into.
IDEXX Laboratories EPS (Diluted) Calculation
EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.
IDEXX Laboratories's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as
EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $10.10
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
IDEXX Laboratories EPS (Diluted) Related Terms
Thank you for viewing the detailed overview of IDEXX Laboratories's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
IDXX has been successfully added to your 